A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate
Latest Information Update: 05 Nov 2021
At a glance
- Drugs ASP 5094 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Proof of concept; Therapeutic Use
- Sponsors Astellas Pharma
- 31 Oct 2018 Status changed from active, no longer recruiting to completed.
- 11 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 19 Oct 2017 Status changed from not yet recruiting to recruiting.